The Semi-Permanent Health Fix Sorting out Britain's Most Embarrassing Health Problem

NOTTINGHAM, UK, July 04, 2012 (Press-News.org) Semi-permanent beauty treatments such as botox, fillers and chemical peels have increased in popularity in recent years in the UK. The British Association of Aesthetics Plastic Surgeons recorded a 6.7% rise in the number of facial rejuvenation procedures [1] among its members as the nation strives to look younger. And many women use the Merina coil as their chosen form of contraception, which lasts for five years. But could health problems happening on the inside also be fixed by semi-permanent solutions?

Deflux (http://www.defluxsui.com) certainly suggests so. If a health problem is causing embarrassment and stopping the sufferer getting on with life, finding a solution is important. However the thought of invasive surgery, painful side effects and taking time off work can sometimes prevent people from seeking treatment.

Research carried out by Oceana Therapeutics [2] revealed that one of the most embarrassing health conditions women suffer from is stress urinary incontinence, with 42% of respondents saying they would be least likely to talk about incontinence to their GP than any other topic. Only 39% of women know about surgery as a solution for incontinence and the most talked about surgery options are usually permanent ones.

However, a semi-permanent treatment exists which offers women a non-invasive way to rectify the problem, with minimal side effects and allowing you back to work within 48 hours. Deflux is a gel used in a procedure called injection therapy (http://www.defluxsui.com) or urethral bulking, which can quickly help improve the lives of women suffering from bladder weakness. Just as a filler plumps up facial skin, when Deflux containing Dextranomer and hyaluronic acid is injected into the urethra endoscopically, it creates a bulking effect in the bladder, which prevents urine leakage.

For women with busy lives, who are not strangers to semi-permanent beauty fixes, injection therapy could be the answer to solving secret health problems that have been swept under the carpet and ignored for years. Steve Foley, Consultant Urologist at the Royal Berkshire Hospital who performs the treatment on a regular basis says, "It is such a shame that women are really afraid to come forward and talk to their GP about the issue of incontinence. Bladder weakness is a silent "epidemic" that women are really scared to come forward about, but injection therapy is a quick and simple procedure to rectify the problem."

Injection therapy can be carried out under local sedation or general anaesthetic and there is no need for an overnight stay in hospital, which is ideal for busy working women with careers and children to juggle. The bulking affect achieved by the procedure will last for approximately five years before it needs to be repeated, the same length of time a child is at primary school.

Women can return to normal activity within 24-48 hours, which means the treatment could be carried out on Friday and the patient could continue their normal routine on Monday morning. The treatment lasts for up to five years and does not affect any more major surgery required at a later stage. In clinical trials the procedure had a 74% success rate in the mild to moderate incontinent group.

So for the 81% of women in the UK who only know about pelvic floor exercises as a solution for incontinence, http://www.defluxsui.com explains how a semi-permanent treatment could be the solution to their problems.

[1] http://www.dailymail.co.uk/femail/article-1257962/The-future-face-40-Botox-fillers-high-tech-face-creams-mean-Big-Four-0-doesnt-look-like-used-to.html
[2] Survey conducted by Redshift Research with 500 men and 500 women.

About Deflux : Deflux gel is a viscous substance consisting of two components: dextranomer (Dx) microspheres and stabilised hyaluronic acid of non-animal origin (NASHA ). Deflux is completely safe and has been successfully used for a decade to treatment more than 200,000 children affected with vesicoureteral reflux. In the treatment of SUI, the dextranomer beads act as the bulking agent and have been shown to remain at the injection site for up to four years. The hyaluronic acid is the carrier agent, which disappears from the body.